Accueil   Diary - News   All news PX’THERAPEUTICS and ADVAXIS to collaborate for the process development of lm based immunotherapies

PX’THERAPEUTICS and ADVAXIS to collaborate for the process development of lm based immunotherapies


PX’Therapeutics, a CDMO (Contract Development and Manufacturing Organization) has signed an agreement with Advaxis, Inc., a US-based, clinical stage biotechnology company, to support it in the process development of cancer immunotherapies based on Advaxis’ proprietary, attenuated Listeria monocytogenes (Lm) platform.



PX’Therapeutics will support Advaxis in taking its drug discovery cycle to the next level, optimizing process development and further discovery of the impact of bacterial culture parameters on product quality. This will ultimately result in the development of a robust industrial production process.


“Partnering with PX’Therapeutics will help catapult our Lm-Technology production process and advance our mission to put our technologies in the hands of patients who desperately need them,” said Michael Grace, Vice President of Technical Operations at Advaxis. Claire Untereiner, COO of PX’Therapeutics commented: “We are really excited about this new collaboration! PX’Therapeutics looks forward to bringing its expertise to the development of this important project.”


Read the press release



PX’Therapeutics is a Contract Development and Manufacturing Organization (CDMO) specializing in the development of biologics (proteins including antibodies and antibody fragments, cells, and micro-organisms), for research and clinical applications. With more than 1,000 projects implemented since its creation in 2000,  PX’Therapeutics is recognized for its scientific expertise coupled with state-of-the-art GMP capacities, in addition to team flexibility and committed dedication to the success of customers’ projects. Today, the company’s mission is to accelerate the development of biologics thanks to a combination of services, from lead optimization and process development through to GMP manufacturing and CMC consulting.